Abstract
Abstract H1 Patents — European patents — Pharmaceuticals — Antibody production — Genetic engineering — Transgenic mice — Infringement — Construction — Insufficiency — Biogen insufficiency — Nature of the invention — Whether a principle of general application — Enablement — Whether the scope of monopoly exceeding technical contribution to the art — Appeal to Supreme Court
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
